Navigation Links
Blood test for lung cancer may be possible
Date:5/19/2008

ATS 2008, TORONTOA simple blood test may be able to detect lung cancer in its earliest stages with unprecedented accuracy, according to new research to be presented at American Thoracic Societys 2008 International Conference in Toronto on Tuesday, May 20.

The possibility of developing a non-invasive test to distinguish cancerous from benign lesions in the lungs has enormous implications, not just for the world of medicine, but for every individual patient who has gone through the harrowing experience of having to wait for conclusive biopsy results after preliminary testing.

CT screening results in the detection of lung nodules in 20 to 60 percent of subjects, said Anil Vachani, M.D., assistant professor of medicine at the University of Pennsylvania. This high false-positive rate requires patients to undergo extensive follow-up investigations, such as serial CT scans, PET scans or biopsies. This test may be able to obviate the need for such things if it is developed into a large scale diagnostic tool.

Because lung cancer is a very diverse disease, screening for it can be very difficult. The researchers hoped to identify a stable and consistent way of determining the presence of lung cancer by testing for the gene expression of white blood cells.

Rather than screening for factors released by the incipient tumor into the blood stream, the test Dr. Vachani and colleagues used looked at gene expression in the subjects own circulating white blood cells. We found that the types of genes present in these cells could tell us whether or not cancer was present, explained Dr. Vachani.

To test the accuracy and validity of the method, the researchers recruited 44 patients with early stage lung cancer and 52 control subjects who were matched for age, smoking status, gender and race. They then used a number of genetic arrays to determine the best targets for detecting the presence of cancer. They found that a 15 gene array had the highest accuracy, at 87 percent.

These findings suggest that lung cancers interact with circulating white blood cells and change the types of genes that are active in these cells. This finding can be potentially used to develop a non-invasive diagnostic test for patients suspected of having lung cancer, said Dr. Vachani. A diagnostic test that could more accurately determine the risk of cancer in patients would be extremely valuable and have very important economic implications by reducing unnecessary surgery, biopsies and repeated imaging tests.

We are planning to perform validation studies to further evaluate the utility of this approach for diagnosing lung cancer in a larger population, concluded Dr Vachani. If our results are encouraging, we would like to test this in a prospective clinical trial.


'/>"/>

Contact: Keely Savoie
ksavoie@thoracic.org
212-315-8620
American Thoracic Society
Source:Eurekalert

Related medicine news :

1. Specific antagonism lowers blood pressure
2. Restricting Blood Flow May Help Heart Bypass Patients
3. FDA Updates Prescription Guidelines for Blood Thinner
4. Doctors Often Miss High Blood Pressure in Kids
5. Back to School Means Return of School Blood Drives
6. Blood-flow detector software show promise in preventing brain damage
7. FDA Approves New Roche West Nile Virus Blood Screening Test
8. Australian-led international study shows blood pressure drugs cut death rate in type 2 diabetes
9. Laser blasts viruses in blood
10. Study Demonstrates Marteks Algal DHA Oil Improves Blood Triglyceride Lipid Levels
11. LifeMasters Provides Tips for Maintaining a Healthy Blood Cholesterol Level
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/7/2016)... ... December 07, 2016 , ... Augustine ... services to families and business owners in the greater Dallas metropolitan area, is ... Dallas Fallen Officer Foundation. , Established in 2009 by active police professionals in ...
(Date:12/7/2016)... (PRWEB) , ... December 07, 2016 , ... Sharon Kleyne, ... Global Climate Change and Your Health on Voice of America, declared on her radio ... call attention to the fact that when these bullies attack leaders in corporate America, ...
(Date:12/7/2016)... ... 07, 2016 , ... 1105 Media’s Live From program has ... Awards competition. Live From won in the Use of Social Media category. The ... projects undertaken by the media industry’s most innovative marketing professionals. , ...
(Date:12/7/2016)... ... 2016 , ... Maureen McLaughlin, LA.c., a certified acupuncturist, is ... Connecticut (RMACT). McLaughlin brings nearly 20 years of experience with fertility patients to ... their family building goals. Acupuncture helps fertility patients by supporting the ...
(Date:12/7/2016)... Va. (Dec. 3, 2016) , ... (PRWEB) December ... ... nation’s only patient advocacy nonprofit for individuals impacted by cerebral cavernous angiomas, was ... in New Mexico with a patient engagement program. New Mexico has more people ...
Breaking Medicine News(10 mins):
(Date:12/7/2016)...   Arena Pharmaceuticals, Inc. (NASDAQ: ... in the ralinepag phase 2 trial.  Ralinepag is an ... for the treatment of pulmonary arterial hypertension (PAH). The ... "This marks an important step in the development ... on our pipeline," said Amit Munshi , Arena,s ...
(Date:12/7/2016)... Conn. , Dec. 7, 2016 According to ... in more than one-third (38%) of patients with non-small cell ... epidermal growth factor receptor (EGFR) genetic mutation status. The findings ... ( LBA ID #6067 #P3.02b ) at the ... Vienna, Austria . The survey results revealed ...
(Date:12/7/2016)... LONDON , Dec. 7,2016  Based ... drug delivery industry, Frost & Sullivan recognizes ... Frost & Sullivan Award for Enabling Technology ... plug the loopholes in traditional drug delivery ... and liquid microneedle-based drug delivery technologies, Memspatch ...
Breaking Medicine Technology: